	贸易债权人		日
AbbVie	USD 3.59B	28.65B	2025-12
Amgen	USD 19.52B	1.37B	2026-03
Anika Therapeutics	USD 6.34M	298K	2026-03
Arrowhead Research	USD 30.75M	2.19M	2026-03
AstraZeneca	USD 22.51B	2.78B	2026-03
BioCryst Pharmaceuticals	USD 10.96M	4.87M	2026-03
Biogen	USD 358.5M	73.5M	2026-03
Bristol-Myers Squibb	USD 4.23B	659M	2026-03
Enanta Pharmaceuticals	USD 1.88M	63K	2025-12
Gilead Sciences	USD 645M	70M	2026-03
GlaxoSmithKline	GBP 14.34B	1.05B	2026-03
Halozyme Therapeutics	USD 14.1M	6.8M	2026-03
Heron Therapeutics	USD 8.97M	24K	2026-03
Immunic	USD 11.01M	873K	2026-03
Incyte	USD 228.62M	1.41B	2026-03
Insmed	USD 73.38M	6.53M	2026-03
Ionis Pharmaceuticals	USD 26.03M	2.05M	2026-03
J&J	USD 10.46B	1.53B	2026-03
Karyopharm Therapeutics	USD 4M	1.39M	2025-12
Ligand Pharmaceuticals	USD 37.11M	33.87M	2026-03
Merck	USD 3.86B	541M	2026-03
Neurocrine Biosciences	USD 691.3M	145.8M	2026-03
Novartis	USD 4.32B	134M	2026-03
Novavax	USD 16.1M	8.48M	2026-03
Pfizer	USD 4.51B	734M	2026-03
PTC Therapeutics	USD 25.48M	20M	2026-03
Roche Holding	CHF 5.78B	1.27B	2025-12
Sarepta Therapeutics	USD 70.38M	210.46M	2026-03
Vertex Pharmaceuticals	USD 3.47B	40.6M	2026-03